A REVOLUTIONARY APPROACH WITH A GAME-CHANGING TECHNOLOGY
All-ScaleFlow™-based-equipment allows to produce mRNA vaccines and therapeutics faster, all over the world, at any scale!
Doses
Minimum scale
Doses
Annual capacity
Only
Equipment footprint
PARTNERS
They trust us
NEWS
Dillico announces the closing of a €7.5 million financing round to launch the commercialization of its innovative solution for the manufacturing of messenger RNA vaccines and therapies
Meylan, France, July 9, 2025 - Dillico announces the completion of a financing round with Angelor, the Fonds Régional Avenir Industrie of the Auvergne-Rhône-Alpes Region (advised by UI Investissement), the French Tech Seed [...]
Join our Team – Our Offers
Want to join our team ? May be an opportunity for you: mRNA-LNP Senior Process Development Scientist Biochemistry Lab Technician Product Marketing Manager – Biopharma Manufacturing Solutions Responsable Administratif et Financier Biotech/Pharma Process [...]
National Day of Biomedicine Bioproduction – June 5, 2025.
National Day of Biomedicine Bioproduction – June 5, 2025. Physical and digital events across France to help you discover this essential link in the healthcare of tomorrow. The National Day of Bioproduction of [...]